论文部分内容阅读
目的探讨黛力新联合心理干预治疗慢性阻塞性肺疾病(COPD)加重期抑郁焦虑患者的临床疗效。方法收集我院2010年6月～2012年5月COPD急性加重期合并抑郁焦虑患者90例,按照患者治疗方式分为观察组及对照组,两组患者均行常规治疗,观察组患者加用黛力新片口服,并进行系统性心理干预,应用汉密尔顿焦虑量表(HAMA)及汉密尔顿抑郁量表(HAMD)对两组患者的焦虑、抑郁进行评价,同时对两组患者进行肺功能测定,比较治疗前后患者肺功能情况。结果两组患者HAMA、HAMD评分均下降,观察组患者下降明显,与对照组患者比较差异明显(P<0.05);观察组患者肺功能各指标改善优于对照组,两组患者比较差异明显,有统计学意义(P<0.05)。结论黛力新联合心理干预治疗COPD加重期抑郁焦虑,能有效降低患者焦虑、抑郁状态,提高患者的治疗效果,值得在临床推广。
Objective To investigate the clinical effects of combination of Deanin and psychotherapy on patients with depression and anxiety due to chronic obstructive pulmonary disease (COPD). Methods Totally 90 patients with acute and exacerbation of COPD in our hospital from June 2010 to May 2012 were divided into observation group and control group according to the way of treatment. Both groups were treated routinely. The observation group was given Dai Lixin tablets and systemic psychological intervention, the use of Hamilton Anxiety Scale (HAMA) and Hamilton Depression Scale (HAMD) to evaluate the anxiety and depression of the two groups of patients, at the same time the two groups of patients with pulmonary function test, comparative treatment Before and after patients with pulmonary function. Results The scores of HAMA and HAMD decreased in both groups, and the patients in observation group decreased significantly compared with those in control group (P <0.05). The indexes of lung function in observation group improved better than those in control group, and the differences between the two groups were significant There was statistical significance (P <0.05). Conclusion Deanxit combined psychological intervention in the treatment of depression and anxiety in patients with COPD exacerbation can effectively reduce anxiety and depression in patients and improve the therapeutic effect of patients, which deserves clinical promotion.